Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport

AIMS/INTRODUCTION: Recent data showed that dipeptidyl peptidase 4 (DPP‐4) inhibitors exert a lipid‐lowering effect in diabetes patients. However, the mechanism of action is not yet clearly understood. We investigated the effect of anagliptin on cholesterol metabolism and transport in the small intes...

Full description

Saved in:
Bibliographic Details
Published in:J Diabetes Investig
Main Authors: Goto, Moritaka, Furuta, Shinji, Yamashita, Satoko, Hashimoto, Hiroyuki, Yano, Wataru, Inoue, Noriyuki, Kato, Noriaki, Kaku, Kohei
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6215941/
https://ncbi.nlm.nih.gov/pubmed/29754453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12860
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items